Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

NuVasive Yönetim

Yönetim kriter kontrolleri 3/4

NuVasive's CEO'su Chris Barry, Nov2018 tarihinde atandı, in görev süresi 4.83 yıldır. in toplam yıllık tazminatı $ 8.08M olup, şirket hissesi ve opsiyonları dahil olmak üzere 11.1% maaş ve 88.9% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.14% ine doğrudan sahiptir ve bu hisseler $ 2.90M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.7 yıl ve 5.6 yıldır.

Anahtar bilgiler

Chris Barry

İcra Kurulu Başkanı

US$8.1m

Toplam tazminat

CEO maaş yüzdesi11.1%
CEO görev süresi4.8yrs
CEO sahipliği0.1%
Yönetim ortalama görev süresi3.7yrs
Yönetim Kurulu ortalama görev süresi5.6yrs

Son yönetim güncellemeleri

Recent updates

Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

Apr 18
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?

Jan 24
What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?

NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price

Dec 31
NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price

Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

Dec 05
Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well

Nov 13
These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Sep 22
Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

Sep 01
Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

NuVasive Likely Undervalued, But It's Hard To Find Catalysts

Aug 17

Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Aug 11
Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M

Aug 03

NuVasive: Industry Tailwinds More Than Fairly Priced

Jun 13

Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Jun 01
Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

May 11
Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

Apr 20
NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?

Mar 30
At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?

NuVasive's Turnaround Story Needs A Boost From Better Results

Mar 01

Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

Dec 28
Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?

Dec 02
Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?

NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

Nov 11
NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate

Oct 21
NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate

Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital

Sep 29
Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital

At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?

Aug 18
At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?

NuVasive Still Getting No Love With COVID-19 And Competitive Worries

Aug 12

Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Jul 27
Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?

Jun 17
Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?

Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital

May 30
Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital

Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All

May 12
Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All

Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

Mar 30
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?

Mar 09
Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?

Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares

Feb 16
Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares

A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)

Jan 26
A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)

NuVasive stock gains on study results of its X360 surgery approach

Jan 06

What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Jan 05
What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

CEO Tazminat Analizi

Chris Barry'un ücretlendirmesi NuVasive'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2023n/an/a

US$28m

Mar 31 2023n/an/a

US$20m

Dec 31 2022US$8mUS$897k

US$40m

Sep 30 2022n/an/a

-US$20m

Jun 30 2022n/an/a

-US$40m

Mar 31 2022n/an/a

-US$37m

Dec 31 2021US$8mUS$875k

-US$64m

Sep 30 2021n/an/a

-US$26m

Jun 30 2021n/an/a

US$2m

Mar 31 2021n/an/a

-US$50m

Dec 31 2020US$5mUS$735k

-US$37m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

US$61m

Dec 31 2019US$5mUS$800k

US$65m

Sep 30 2019n/an/a

US$48m

Jun 30 2019n/an/a

US$52m

Mar 31 2019n/an/a

US$49m

Dec 31 2018US$5mUS$92k

US$12m

Tazminat ve Piyasa: Chris 'nin toplam tazminatı ($USD 8.08M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 5.54M ).

Tazminat ve Kazançlar: Chris 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Chris Barry (50 yo)

4.8yrs

Görev süresi

US$8,077,095

Tazminat

Mr. J. Christopher Barry, also known as Chris, serves as Chief Executive Officer and Director of NuVasive, Inc., since November 5, 2018. Mr. Barry served commercial and leadership roles at Covidien. He has...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
J. Barry
CEO & Director4.8yrsUS$8.08m0.14%
$ 2.9m
Matthew Harbaugh
Principal Accounting Officer3.7yrsUS$2.97m0.020%
$ 418.2k
Dale Wolf
Senior Vice President of Global Operations3.7yrsUS$1.48m0.017%
$ 355.5k
Nathaniel Sisitsky
Senior VP5.3yrsUS$1.54m0.042%
$ 869.2k
Michael Farrington
Senior Vice President of People & Cultureless than a yearUS$1.03m0.0059%
$ 123.8k
Ryan Donahoe
Senior VP & Chief Technology Officer2yrsVeri yokVeri yok
Juliet Cunningham
Vice President of Investor Relationsno dataVeri yokVeri yok
Sean Freeman
Senior Vice President of Strategy & Corporate Development3.8yrsVeri yokVeri yok
Lisa Pecora
Vice President & Head of Global Commercial Finance5.3yrsVeri yokVeri yok
Aviva McPherron
Senior Vice President of Information Technology1.7yrsVeri yokVeri yok
Tristan Ribar
Vice President5.3yrsVeri yokVeri yok

3.7yrs

Ortalama Görev Süresi

48yo

Ortalama Yaş

Deneyimli Yönetim: NUVA 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.7 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
J. Barry
CEO & Director4.8yrsUS$8.08m0.14%
$ 2.9m
John DeFord
Independent Director5.6yrsUS$260.01k0%
$ 0
Robert Friel
Independent Director7.6yrsUS$260.01k0%
$ 0
Vickie Capps
Independent Director8.3yrsUS$280.01k0.0038%
$ 79.4k
R. Huennekens
Independent Director4.9yrsUS$260.01k0.0026%
$ 54.0k
Daniel Wolterman
Independent Chair8.2yrsUS$405.01k0%
$ 0
Leslie Norwalk
Independent Director9.3yrsUS$270.01k0.0059%
$ 123.0k
Siddhartha Kadia
Independent Director2.6yrsUS$260.01k0.0071%
$ 148.7k
Amy Raimundo
Independent Director2.1yrsUS$260.01k0%
$ 0

5.6yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: NUVA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.6 yıldır).